Completed PHASE4 INTERVENTIONAL 2-arm NCT01596998

Plasma Concentrations of Levobupivacaine With and Without Epinephrine in Transversus Abdominis Plane Blocks

Comparison of Plasma Concentrations of Levobupivacaine With and Without Epinephrine for Transversus Abdominis Plane Block Under Ultrasound.

Sponsor: Pontificia Universidad Catolica de Chile

Conditions Transversus Abdominis Plane Block

Interventions Determining the extent of the block Levobupivacaine with epinephrine Levobupivacaine without epinephrine Monitoring

Updated 5 times since 2017 Last updated: May 10, 2012 Started: Dec 31, 2011 Primary completion: Apr 30, 2012 Completion: Apr 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01596998, this PHASE4 trial focuses on Transversus Abdominis Plane Block and remains completed. Sponsored by Pontificia Universidad Catolica de Chile, it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Dec 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pontificia Universidad Catolica de Chile

Data source: Pontificia Universidad Catolica de Chile

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Santiago, Chile